No. 5: GE Healthcare
2017 revenues: $19,116,000,000
2017 R&D spend: $1,016,000,000
Fiscal year ending: December 31, 2017
Kieran Murphy, president & CEO; Emmanuel Ligner, president & CEO of GE Healthcare Life Sciences; Maher Abouzeid, president & CEO of GE Healthcare, Eastern Growth Markets; Tom McGuinness, president & CEO, GE Healthcare Imaging; Terri Bresenham, chief innovation officer, GE Healthcare; Lee Cooper, president & CEO, U.S. & Canada; Rachel Duan, president & CEO, GE Healthcare China; Laurent Dubois, CEO, GE Healthcare Partners; Catherine Estrampes, president & CEO, GE Healthcare Europe; Thomas Mitchell, acting VP, global supply chain; Laura O’Donnell, VP & general counsel; Monish Patolawala, VP, CFO & chief digital officer; Soichiro Tada, president & CEO, GE Healthcare Japan; Luiz Verzegnassi, president & CEO, GE Healthcare Latin America; Thomas Westrick, VP & chief quality officer; Anders Wold, president & CEO, clinical care solutions; Will Spiers, chief communications officer; Jan Makela, president & CEO, GE Healthcare Global Services; Katya Kruglova, VP, human resources; Myra Eskes, president & CEO, GE Healthcare ASEAN, Korea & ANZ; Nalinikanth (Nal) Gollagunta, president & CEO, GE Healthcare India & South Asia; Farid Fezoua, president & CEO, GE Healthcare Africa
Parent company General Electric is looking to transform itself under new CEO John Flannery (the former healthcare chief who succeeded Jeff Immelt last year), announcing plans to shift its worldwide headquarters to Boston and spin out its GE Healthcare subsidiary as a stand-alone, publicly traded entity. GE is also planning an “orderly separation” from its 62.5% stake in the BHGE oil and gas servicing and equipment unit over the next two to three years. Chicago-based GE Healthcare has long been a bright spot for GE, consistently posting sales and profit gains despite overall declines at GE. In April 2018 the division agreed to sell its value-based healthcare division to Veritas Capital for $1.05 billion in cash.